mitomycin has been researched along with Delayed Hypersensitivity in 24 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To know the dermatologic side effects of intravesical treatment with Mitomycin C in non muscle invasive bladder cancer." | 7.83 | Dermatological side effects of intravesical Mitomycin C: Delayed hypersensitivity. ( Castillo Pacheco, C; Colomer Gallardo, A; González Satue, C; Ibarz Servio, L; Martínez Rodríguez, R, 2016) |
| "Primary outcome measurement was recurrence-free survival (RFS)." | 6.77 | Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: results from a prospective randomized phase III trial. ( Caris, CT; Janzing-Pastors, MH; Lammers, RJ; Witjes, JA; Witjes, WP, 2012) |
| "To know the dermatologic side effects of intravesical treatment with Mitomycin C in non muscle invasive bladder cancer." | 3.83 | Dermatological side effects of intravesical Mitomycin C: Delayed hypersensitivity. ( Castillo Pacheco, C; Colomer Gallardo, A; González Satue, C; Ibarz Servio, L; Martínez Rodríguez, R, 2016) |
| "A 71-year-old man developed an exfoliative dermatitis of the palms of the hands and soles of the feet, and a generalized itch, during treatment with intravesical instillations of mitomycin C for an undifferentiated carcinoma of the bladder." | 3.70 | Type III and type IV hypersensitivity reactions due to mitomycin C. ( Bruynzeel, DP; Kunkeler, L; Nieboer, C, 2000) |
| "Primary outcome measurement was recurrence-free survival (RFS)." | 2.77 | Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: results from a prospective randomized phase III trial. ( Caris, CT; Janzing-Pastors, MH; Lammers, RJ; Witjes, JA; Witjes, WP, 2012) |
| "Two lymphomas were found in, and isolated from A (H-2a) mice in which permanent transplantation tolerance was induced to CBA (H-2k) histocompatibility antigens by the neonatal injection of (CBAxA)F1 spleen cells." | 1.29 | MHC-specific graft-protective and delayed-type hypersensitivity (DTH) suppressive activity of a CD4+ CD8+, alpha beta T cell receptor (TCR) positive lymphoma isolated from a tolerant mouse. ( Baranyi, L; Benner, R; Jánossy, T; Knulst, AC; Végh, P; Vizler, C, 1993) |
| "Mitomycin C is an alkylating agent, used by intravesical instillation to treat carcinoma of the bladder." | 1.28 | Dermatitis due to intravesical mitomycin C: a delayed-type hypersensitivity reaction? ( Colver, GB; Hunter, JA; Inglis, JA; McVittie, E; Spencer, MJ; Tolley, DA, 1990) |
| "The growth of Meth A (MA) tumors was suppressed in tumor-antigen-specific manner in BALB/c mice immunized with mitomycin C-treated MA (MMC-MA) cells in saline or in Freund's complete adjuvant (FCA)." | 1.27 | Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells. ( Himeno, K; Matsumoto, T; Miake, S; Mitani, M; Mori, K; Nomoto, K, 1986) |
| "Mitomycin C was used as the chemotherapeutic agent and BCG as the immunopotentiating agent." | 1.26 | [Experimental study on local immunochemotherapy]. ( Fujita, Y; Imai, H; Kageyama, N; Kasuga, M; Majima, S; Sakita, M; Torii, T; Yamane, T, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (54.17) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colomer Gallardo, A | 1 |
| Martínez Rodríguez, R | 1 |
| Castillo Pacheco, C | 1 |
| González Satue, C | 1 |
| Ibarz Servio, L | 1 |
| Fernandez, DG | 1 |
| Fernández, AF | 1 |
| Vallejo, MS | 1 |
| Osorio, JL | 1 |
| Anguita, MJ | 1 |
| Jimenez, AL | 1 |
| Lammers, RJ | 1 |
| Witjes, WP | 1 |
| Janzing-Pastors, MH | 1 |
| Caris, CT | 1 |
| Witjes, JA | 1 |
| Cao Avellaneda, E | 1 |
| López López, AI | 1 |
| Maluff Torres, A | 1 |
| Jiménez, RM | 1 |
| Escudero Bragante, JF | 1 |
| López Cubillana, P | 1 |
| Prieto González, A | 1 |
| Pérez Albacete, M | 1 |
| Ashour, HM | 1 |
| Niederkorn, JY | 1 |
| Kasuga, M | 2 |
| Sakita, M | 2 |
| Yamane, T | 2 |
| Torii, T | 2 |
| Tamai, M | 1 |
| Kageyama, N | 2 |
| Fujita, Y | 2 |
| Majima, S | 2 |
| Kearney, R | 1 |
| Harrop, P | 1 |
| Okabe, M | 1 |
| Imai, R | 1 |
| Morimoto, M | 1 |
| Imai, H | 1 |
| Balemans, LT | 1 |
| Vegt, PD | 1 |
| Steerenberg, PA | 1 |
| De Boer, EC | 1 |
| Van Swaaij, A | 1 |
| De Vries, RE | 1 |
| Van der Meijden, AP | 1 |
| Den Otter, W | 1 |
| Jánossy, T | 1 |
| Baranyi, L | 1 |
| Knulst, AC | 1 |
| Vizler, C | 1 |
| Benner, R | 2 |
| Végh, P | 1 |
| Echechipía, S | 1 |
| Alvarez, MJ | 1 |
| García, BE | 1 |
| Olaguíbel, JM | 1 |
| Rodriguez, A | 1 |
| Lizaso, MT | 1 |
| Acero, S | 1 |
| Tabar, AI | 1 |
| Tanigawa, T | 1 |
| Gotoh, M | 1 |
| Nagano, H | 1 |
| Ota, H | 1 |
| Fukuzaki, T | 1 |
| Sakon, M | 1 |
| Monden, M | 1 |
| Kunkeler, L | 1 |
| Nieboer, C | 1 |
| Bruynzeel, DP | 1 |
| Colver, GB | 1 |
| Inglis, JA | 1 |
| McVittie, E | 1 |
| Spencer, MJ | 1 |
| Tolley, DA | 1 |
| Hunter, JA | 1 |
| Fujii, T | 1 |
| Sugita, N | 1 |
| Kobayashi, Y | 1 |
| Saito, K | 1 |
| Iijima, H | 1 |
| Matsunaga, K | 1 |
| Ando, T | 1 |
| Oguchi, Y | 1 |
| Morita, I | 1 |
| Yoshikumi, C | 1 |
| Mitani, M | 2 |
| Mori, K | 2 |
| Himeno, K | 3 |
| Nomoto, K | 3 |
| Bianchi, AT | 1 |
| Schilham, MW | 1 |
| Young, P | 1 |
| Lefkovits, I | 1 |
| Tokuda, N | 1 |
| Mayumi, H | 1 |
| Gondo, H | 1 |
| Fan, JL | 1 |
| Matsumoto, T | 1 |
| Miake, S | 1 |
| Sewell, WA | 1 |
| de Moerloose, PA | 1 |
| McKimm-Breschkin, JL | 1 |
| Vadas, MA | 1 |
| Tamura, S | 1 |
| Tanaka, H | 1 |
| Kikuta, K | 1 |
| Kobayashi, T | 1 |
| Sato, H | 1 |
| Sato, Y | 1 |
| Abe, F | 1 |
| Hayashi, M | 1 |
| Horinishi, H | 1 |
| Matsuda, A | 1 |
| Ishizuka, M | 1 |
| Umezawa, H | 1 |
| Kreider, JW | 1 |
| Howell, LE | 1 |
| Bartlett, GL | 1 |
1 trial available for mitomycin and Delayed Hypersensitivity
| Article | Year |
|---|---|
Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: results from a prospective randomized phase III trial.
Topics: Administration, Cutaneous; Administration, Intravesical; Aged; Disease-Free Survival; Female; Hemocy | 2012 |
23 other studies available for mitomycin and Delayed Hypersensitivity
| Article | Year |
|---|---|
Dermatological side effects of intravesical Mitomycin C: Delayed hypersensitivity.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Humans; Hypersensitivity, Delayed; Mitomy | 2016 |
Delayed hypersensitivity to Mitomycin C.
Topics: Antibiotics, Antineoplastic; Humans; Hypersensitivity, Delayed; Male; Middle Aged; Mitomycin; Skin T | 2009 |
[Type IV hypersensitivity to intravesical mitomycin].
Topics: Administration, Topical; Aged; Alkylating Agents; Humans; Hypersensitivity, Delayed; Male; Mitomycin | 2005 |
Expansion of B cells is necessary for the induction of T-cell tolerance elicited through the anterior chamber of the eye.
Topics: Adoptive Transfer; Animals; Anterior Chamber; Antigen-Presenting Cells; B-Lymphocytes; Cell Prolifer | 2007 |
Intratumor chemoimmunotherapy with mitomycin C and BCG in C3H/He mice transplanted with MH134.
Topics: Animals; Antibody Formation; BCG Vaccine; Hypersensitivity, Delayed; Immunotherapy; Lymphatic Metast | 1983 |
Modulation of anti-tumour immunity induced by syngeneic mitomycin C-treated murine tumour cells.
Topics: Animals; Antigens, Neoplasm; Cross Reactions; Female; Graft Rejection; Hypersensitivity, Delayed; Im | 1984 |
The action of 7-N-(p-hydroxyphenyl)mitomycin C [M-83] in suppressing murine immune response.
Topics: Animals; Antibiotics, Antineoplastic; Hemolytic Plaque Technique; Hypersensitivity, Delayed; Immunos | 1982 |
[Experimental study on local immunochemotherapy].
Topics: Animals; Antibiotics, Antineoplastic; BCG Vaccine; Hemolytic Plaque Technique; Hypersensitivity, Del | 1982 |
Effects of sequential intravesical administration of mitomycin C and bacillus Calmette-Guérin on the immune response in the guinea pig bladder.
Topics: Administration, Intravesical; Animals; Bacterial Adhesion; BCG Vaccine; Female; Guinea Pigs; Histoco | 1994 |
MHC-specific graft-protective and delayed-type hypersensitivity (DTH) suppressive activity of a CD4+ CD8+, alpha beta T cell receptor (TCR) positive lymphoma isolated from a tolerant mouse.
Topics: Animals; Animals, Newborn; CD4 Antigens; CD8 Antigens; Cell Division; Flow Cytometry; Fluorescent An | 1993 |
Generalized dermatitis due to mitomycin C patch test.
Topics: Aged; Antibiotics, Antineoplastic; Drug Eruptions; Humans; Hypersensitivity, Delayed; Male; Mitomyci | 1995 |
Injection of mitomycin-C-treated spleen cells induces donor-specific unresponsiveness to cardiac allografts in rats.
Topics: Adoptive Transfer; Animals; Heart Transplantation; Hypersensitivity, Delayed; Male; Mitomycin; Preop | 1999 |
Type III and type IV hypersensitivity reactions due to mitomycin C.
Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Carcinoma; Dermatitis, Exfoliative; | 2000 |
Dermatitis due to intravesical mitomycin C: a delayed-type hypersensitivity reaction?
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Alkylating Agents; Antigen-Presenting Cells; | 1990 |
Treatment with Krestin combined with mitomycin C, and effect on immune response.
Topics: Animals; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Female; Hypersensitivit | 1989 |
Anti-tumor cytostatic mechanism and delayed-type hypersensitivity against a syngeneic murine tumor. Comparison between neonatally thymectomized mice and congenitally athymic nude mice.
Topics: Animals; Animals, Newborn; Cell Division; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic | 1989 |
In vivo priming of helper and suppressor T cells by alloantigens. Frequency analysis with the use of an in vitro limiting dilution assay.
Topics: Animals; Antibody Formation; Dose-Response Relationship, Immunologic; Hypersensitivity, Delayed; Imm | 1987 |
Drug-induced in vitro tolerance to allogeneic antigens. II. Further analysis of in vitro-tolerized spleen cells in a fully allogeneic murine combination.
Topics: Animals; Animals, Newborn; Crosses, Genetic; Cytotoxicity, Immunologic; Fluorouracil; Graft vs Host | 1988 |
Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
Topics: Animals; Antibodies, Neoplasm; Antibody Specificity; Cells, Cultured; Cytotoxicity, Immunologic; Fib | 1986 |
Pertussigen enhances antigen-driven interferon-gamma production by sensitized lymphoid cells.
Topics: Animals; Antigen-Presenting Cells; Emetine; Female; Hypersensitivity, Delayed; In Vitro Techniques; | 1986 |
Mechanism by which pertussis toxin breaks unresponsiveness of delayed-type hypersensitivity to sheep red blood cells in mice.
Topics: Animals; Antigens, Ly; Erythrocytes; Female; Hypersensitivity, Delayed; Mice; Mice, Inbred C57BL; Mi | 1986 |
Enhancement of graft-versus-host reaction and delayed cutaneous hypersensitivity in mice by ubenimex.
Topics: Adjuvants, Immunologic; Aging; Animals; Dose-Response Relationship, Drug; Graft vs Host Reaction; Hy | 1986 |
Characteristics of T cells involved in the expression of delayed hypersensitivity and tumor rejection immunity to 13762A rat mammary adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Antigens, Surface; Cyclophosphamide; Female; Hydroxyure | 1985 |